is this summary of the folloiwing evidence too long if there is unecsary part could you remove it

Question

Figure 4 shows that CRISPR b significantly increased γ-globin expression in K562 cells compared to untreated cells, while CRISPR a and c did not. This indicates that CRISPR b effectively targeted the SOX6 binding site to elevate γ-globin levels, demonstrating the potential of CRISPR/Cas9 for enhancing fetal hemoglobin production as a therapeutic approach for β-thalassemia.
Panel C shows that CRISPR gene editing significantly increased fetal hemoglobin (HbF) as a percentage of total hemoglobin in erythroid cells from 10 healthy donors, with error bars indicating the standard deviation of the results.

Answer 1

The summary could be shortened to the following: "Figure 4 demonstrates that CRISPR b effectively targeted the SOX6 binding site to increase γ-globin expression in K562 cells, while CRISPR a and c did not. This suggests the potential of CRISPR/Cas9 for enhancing fetal hemoglobin production as a therapeutic approach for β-thalassemia. Panel C shows that CRISPR gene editing increased fetal hemoglobin levels in erythroid cells from 10 healthy donors."